News The US FDA Accepts GSK’s Depemokimab Review Application for Asthma with Type 2 Inflammation and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)ByRidhi RastogiMarch 4, 20250Comments
News Boston Scientific Enters into a Definitive Agreement to Acquire SoniVie for $600MByRidhi RastogiMarch 4, 20250Comments
News Johnson & Johnson’s Darzalex (daratumumab) Receives the CHMP’s Positive Opinion for Multiple MyelomaByRidhi RastogiMarch 4, 20250Comments
News Daiichi Sankyo Reports Interim Data of P-III (DESTINY-Gastric04) Study Evaluating Enhertu in HER2+ Metastatic Gastric Cancer PatientsByRidhi RastogiMarch 4, 20250Comments
News AbbVie Enters into a Global License Agreement with Gubra to Develop & Commercialize GUB014295 to Treat ObesityByRidhi RastogiMarch 4, 20250Comments
News Bavarian Nordic Reports the EC’s Approval of Vimkunya to Prevent ChikungunyaByRidhi RastogiMarch 3, 20250Comments
News BridgeBio Oncology Therapeutics (BBOT) Enters into Business Combination Agreement with Helix Acquisition Corp. II to Develop RAS and PI3Kα-Targeting DrugsByRidhi RastogiMarch 3, 20250Comments
News GSK Presents Pooled Analysis from P-III (ANCHOR-1 & 2) Trial of Depemokimab for CRSwNP at AAAAI/WAO Joint Congress 2025ByRidhi RastogiMarch 3, 20250Comments
